Consensus‐based recommendations for titrating cannabinoids and tapering opioids for chronic pain control

Opioid misuse and overuse have contributed to a widespread overdose crisis and many patients and physicians are considering medical cannabis to support opioid tapering and chronic pain control. Using a five‐step modified Delphi process, we aimed to develop consensus‐based recommendations on: 1) when and how to safely initiate and titrate cannabinoids in the presence of opioids, 2) when and how to safely taper opioids in the presence of cannabinoids and 3) how to monitor patients and evaluate outcomes when treating with opioids and cannabinoids.

[1]  M. Sydes,et al.  Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. , 2022, European urology.

[2]  Huiru Dong,et al.  Frequent Cannabis Use and Cessation of Injection of Opioids, Vancouver, Canada, 2005-2018. , 2020, American journal of public health.

[3]  B. Okusanya,et al.  Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review , 2020, Systematic Reviews.

[4]  Brian A. King,et al.  Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Preliminary Report. , 2020, The New England journal of medicine.

[5]  M. Layton,et al.  Cannabis Use and Cognition in Adults Prescribed Opioids for Persistent Pain. , 2020, Pain management nursing : official journal of the American Society of Pain Management Nurses.

[6]  Yujiang Fang,et al.  The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. , 2019, Current pharmaceutical biotechnology.

[7]  R. Rubin.  HHS Guide for Tapering or Stopping Long-term Opioid Use. , 2019, JAMA.

[8]  Alex Capano,et al.  Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study , 2019, Postgraduate medicine.

[9]  G. Ginsberg,et al.  E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. , 2019, The Lancet. Respiratory medicine.

[10]  Z. Walsh,et al.  Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis , 2019, PLoS medicine.

[11]  P. Di Ciano,et al.  Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults , 2019, Psychopharmacology.

[12]  Jacob M. Vigil,et al.  The effectiveness of self-directed medical cannabis treatment for pain. , 2019, Complementary therapies in medicine.

[13]  Kevin Rod.  A Pilot Study of a Medical Cannabis - Opioid Reduction Program , 2019, American Journal of Psychiatry and Neuroscience.

[14]  P. Roy,et al.  Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study. , 2019, Pain medicine.

[15]  F. Saad,et al.  Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum. , 2019 .

[16]  Mark Monaghan,et al.  Cannabis and Psychosis: Are We any Closer to Understanding the Relationship? , 2019, Current Psychiatry Reports.

[17]  Nathaniel Morris.  Educating Physicians About Marijuana. , 2019, JAMA internal medicine.

[18]  V. Novack,et al.  Safety and Efficacy of Medical Cannabis in Fibromyalgia , 2019, Journal of clinical medicine.

[19]  L. Minuzzi,et al.  The use of cannabinoids for sleep: A critical review on clinical trials. , 2019, Experimental and clinical psychopharmacology.

[20]  Y. Hurd,et al.  Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. , 2019, The American journal of psychiatry.

[21]  R. Chou,et al.  No Shortcuts to Safer Opioid Prescribing. , 2019, The New England journal of medicine.

[22]  Jacob M. Vigil,et al.  The Association between Cannabis Product Characteristics and Symptom Relief , 2019, Scientific Reports.

[23]  Nick Jikomes,et al.  Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients , 2019, Harm Reduction Journal.

[24]  D. Clauw,et al.  Brief Commentary: Cannabinoid Dosing for Chronic Pain Management , 2019, Annals of Internal Medicine.

[25]  E. Groce.  The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research , 2018, Journal of Medical Regulation.

[26]  F. Blyth,et al.  Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. , 2018, The Lancet. Public health.

[27]  Anup D. Patel,et al.  Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome , 2018, The New England journal of medicine.

[28]  B. Louis,et al.  Cannabis and pain , 2018 .

[29]  D. Boggs,et al.  The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial , 2018, Psychopharmacology.

[30]  D. Hunter,et al.  Synthetic transdermal cannabidiol for the treatment of knee pain due to osteoarthritis , 2018 .

[31]  J. Linder,et al.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults , 2018, Annals of Internal Medicine.

[32]  A. Nielsen,et al.  Evidence‐Based Nonpharmacologic Strategies for Comprehensive Pain Care: The Consortium Pain Task Force White Paper , 2018, Explore.

[33]  V. Novack,et al.  Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. , 2018, European journal of internal medicine.

[34]  G. Bedi,et al.  Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability , 2018, Neuropsychopharmacology.

[35]  P. Kantoff,et al.  Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. , 2018, European urology.

[36]  P. McGuire,et al.  Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. , 2017, The American journal of psychiatry.

[37]  B. Wiese,et al.  A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people , 2017, PloS one.

[38]  L. Bierut,et al.  Physicians-in-training are not prepared to prescribe medical marijuana. , 2017, Drug and alcohol dependence.

[39]  Christopher M. Jones,et al.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health , 2017, Annals of Internal Medicine.

[40]  Rongrui Tang,et al.  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. , 2017, The New England journal of medicine.

[41]  W. van den Brink,et al.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations , 2017, American journal of public health.

[42]  F. Grotenhermen,et al.  An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies , 2017, Cannabis and cannabinoid research.

[43]  A. Reiman,et al.  Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report , 2017, Cannabis and cannabinoid research.

[44]  Joseph W. Frank,et al.  Guideline for opioid therapy and chronic noncancer pain , 2017, Canadian Medical Association Journal.

[45]  Z. Walsh,et al.  Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. , 2017, The International journal on drug policy.

[46]  B. Betz-Stablein,et al.  Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis , 2017, Neuropsychopharmacology.

[47]  S. Haroutounian,et al.  The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study , 2016, The Clinical journal of pain.

[48]  M. Haney,et al.  Sex-dependent effects of cannabis-induced analgesia. , 2016, Drug and alcohol dependence.

[49]  D. Clauw,et al.  Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. , 2016, The journal of pain : official journal of the American Pain Society.

[50]  Aaron J. Bois,et al.  Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology , 2016, BMC Medical Research Methodology.

[51]  Robert Kay,et al.  Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. , 2016, Drug and alcohol review.

[52]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[53]  B. Wilsey,et al.  Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. , 2015, The journal of pain : official journal of the American Pain Society.

[54]  J. Collet,et al.  Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). , 2015, Journal of Pain.

[55]  Penny F Whiting,et al.  Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. , 2015, JAMA.

[56]  R. Chou,et al.  The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[57]  L. Manwell,et al.  A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents. , 2014, Journal of pharmacological and toxicological methods.

[58]  Nora D Volkow,et al.  Adverse health effects of marijuana use. , 2014, The New England journal of medicine.

[59]  B. Feldman,et al.  Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. , 2014, Journal of clinical epidemiology.

[60]  M. Haney,et al.  Investigation of sex-dependent effects of cannabis in daily cannabis smokers. , 2014, Drug and alcohol dependence.

[61]  J. Rehm,et al.  The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies , 2013, Psychological Medicine.

[62]  R. Sandhu,et al.  Maturation of the adolescent brain , 2013, Neuropsychiatric disease and treatment.

[63]  G. Panagis,et al.  Cannabidiol inhibits the reward‐facilitating effect of morphine: involvement of 5‐HT1A receptors in the dorsal raphe nucleus , 2013, Addiction biology.

[64]  N. Benowitz,et al.  Cannabinoid–Opioid Interaction in Chronic Pain , 2011, Clinical pharmacology and therapeutics.

[65]  M. Ware,et al.  The abuse potential of the synthetic cannabinoid nabilone. , 2010, Addiction.

[66]  C. Ehlers,et al.  Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. , 2010, Addictive behaviors.

[67]  D. Wade,et al.  Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients , 2004, Multiple sclerosis.

[68]  H. Kranzler,et al.  Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. , 2004, Drug and alcohol dependence.

[69]  D. Wade,et al.  A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms , 2003, Clinical rehabilitation.

[70]  C. Inturrisi.  Clinical Pharmacology of Opioids for Pain , 2002, The Clinical journal of pain.

[71]  F. Hasson,et al.  Research guidelines for the Delphi survey technique. , 2000, Journal of advanced nursing.

[72]  K. Shepard,et al.  Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. , 1995, Journal of pain and symptom management.

[73]  W. S. Dalton,et al.  Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effects , 1976, Clinical pharmacology and therapeutics.

[74]  G. R. Thompson,et al.  Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys. , 1973, Toxicology and applied pharmacology.

[75]  Norman Crolee Dalkey,et al.  An experimental study of group opinion , 1969 .

[76]  N. Dalkey,et al.  An Experimental Application of the Delphi Method to the Use of Experts , 1963 .

[77]  Z. Cooper,et al.  Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective , 2018, Neuropsychopharmacology.

[78]  W. van den Brink,et al.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. , 2017, American journal of public health.